Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Adding Midazolam to Dual Prophylaxis for Preventing PONV
NCT07668700Phase 2Completed
- Sponsor
- Hameed Latif Hospital
- Start
- Dec 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
A Phase 2 trial of midazolam in postoperative nausea and vomiting (PONV), sponsored by Hameed Latif Hospital. Started Dec 2025; status: completed.
02
Drugs
midazolam
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT07668700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07668700.